Dementia and Alzheimer’s (spring) Flashcards

1
Q

define dementia

A

Chronic progressive mental disorder that adversely affects higher cortical functions including memory, thinking, orientation, comprehension, calculation, learning capacity, language and judgment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is Alzheimer’s disease?

A

Most common form of dementia.

Degenerative cerebral disease with characteristic neuropathological and neurochemical features

Onset and development is slowly but steadily over several years

Progressive deterioration in cognition, function and behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

common symptoms of Alzheimer’s disease

A

Cognitive

  • Memory loss
  • Failing intellect (inability to learn new skills)
  • Poor concentration
  • Language impairment
  • Disorientation/confusion

Non-cognitive

  • Depression
  • Delusion
  • Anxiety
  • Aggression
  • Sleep disturbances
  • Dis-inhibition

Disability

  • Difficulties with activities of daily living
  • Self-neglect
  • Incontinence and other physical disabilities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis of Alzheimer’s disease

A

Symptoms & Memory assessment (Clinical criteria)

MRI and PET Scans for biomarkers (Neuropathological hallmarks)

Outcomes:

  • Memory tests can show problems in particular areas
  • CT and MRI scans may show brain shrinkage (atrophy)
  • SPECT and PET scans may show areas of: Loss of function (fluoro­ deoxyglucose [FDG]­PET), and Presence of AD biomarkers (PET with amyloid-binding radiotracer or chemical marker of cerebrospinal fluid [CSF] amyloid and tau proteins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what do different scores on the Mini Mental State Exam mean?

A

Scored out of 30

  • ≥27 = Normal
  • 19-24 = Mild cognitive impairment
  • 10–18 = Moderate impairment
  • ≤9 = Severe impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does an MRI scan show in Alzheimer’s disease?

advantages of MRI scan?

A

Highlights atrophy in hippocampus and mesiotemporal lobe (MT)

Can detect pre-symptomatic changes

Non-invasive

Reproducible and quantitative read out.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does an FDG scan show in Alzheimer’s disease?

advantages of FDG scan?

A

Highlights deficits in parietal lobe (P) and posterior cingulate gyrus (PCG).

Links metabolic state to synaptic activity.

Open to errors from other metabolic changes.

Useful tool in differentiating dementia’s (e.g. AD vs FTD).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Risk factors for Alzheirmer’s

A
  • Age >65
  • ApoE4 genotype
  • ApoJ genotype
  • TREM2 status
  • History of stroke (hypoxic episodes)
  • Head injury
  • Vascular diseases
  • Diabetes
  • Smoking
  • Drinking
  • Education
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Traumatic brain injury biomarkers

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are early-onset inherited cases of Alzheimer’s caused by?

A

rare mutations in 3 genes: PSEN 1, PSEN 2, APP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

in Alzheimer’s what is scattered throughout the cortex?

A

Amyloid plaques and Neurofibrillary tangles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe the amyloid cascade hypothesis leading to Alzheimer’s

A

Increased Aβ production & Decreased Aβ degradation leading to…

  • ↑Amyloid β accumulation
  • Amyloid β oligomerisation and deposition
  • Inflammatory response (Glial cells)
  • Synapse loss
  • Oxidative stress
  • Ca2+ overload and neuronal death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment strategies for dementia

A

No disease modifying therapy exists for dementia.

Current treatment strategies center around neurotransmitter modulation as a symptomatic approach. In particular, cholinergic and glutamatergic signalling.

  • Acetylcholinesterase Inhibitors
  • N-methyl D-aspartate antagonism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

examples Acetylcholinesterase Inhibitors for dementia

what effects does it have?

how are benefits assessed?

success rate?

side effects?

A

Acetylcholinesterase Inhibitors: Donepezil, Galantamine, Rivastigmine

Effects:

  • Enhance cholinergic transmission and improve cognitive functions
  • Therapeutic effectiveness decreases with increasing neuronal damage
  • Does not prevent progression of disease!

Benefit assessed by repeating the cognitive assessment after 3 months treatment. Discontinue treatment if patient does not respond to therapy!

Only a subset of patients respond

High doses have side effects e.g., nausea, vomiting, diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

give an example of an N-methyl D-aspartate antagonism

effects?

Possible drug interactions?

A

Memantine- Non-competitive antagonist at NMDA receptors.

Effects:

  • Improves cognitive functions
  • Effects evident at late stages of disease
  • Role in early stage of AD unclear…
  • Not certain if it prevents progression of disease…

Possible drug interactions e.g., antipsychotic (see non-cognitive changes and treatments!), anticoagulant (warfarin), analgesic and muscle relaxant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is Anticholinergic Burden (ACB)?

A

Medications with anticholinergic properties can be associated adverse drug reactions.

The anticholinergic effect increases if a stronger anticholinergic is used, or if different anticholinergics are used in combination.

The elderly are more likely to have multiple co-morbidities, and metabolise medicines slower.

Medicines with anticholinergic effects now categorised with an ACB score. 3+ is clinically relevant and alternative treatments should be sought.\

Warfarin (1), Cyclobenzaprine (2), Diphenhydramine (3)

17
Q

what is reccomended in the NICE guidelines for Alzheimer’s disease?

A

Donepezil, Galantamine and Rivastigmine recommended for managing:

  • mild
  • moderate Alzheimer’s disease

Memantine is now recommended as an option for managing:

  • moderate Alzheimer’s disease for people who cannot take AChE inhibitors
  • severe Alzheimer’s disease
  • In combination? Not currently recommended
18
Q

Novel (new) strategies for treating dementia

A
  • Modulating neurotransmission
  • Amyloid based therapies
  • Tau based therapies
  • Oxidative stress reduction
  • Mitochondrial targeted therapy
  • Modulation of calcium homeostasis
  • Anti-inflammatory therapy
  • Drug repurposing
19
Q

BPSD (behavioral and psychological symptoms of dementia)

A
  • Marked agitation
  • Ideation
  • Anxiety
  • Hallucinations
  • Misperceptions
  • Aggressive behavior
  • Depression
20
Q

what would you give for challabging behaviour such as violence, aggression, severe agitation?

what would you give Patients with psychosis and/or agitated behaviour causing significant distress?

what would you give a patient also on Antidepressants?

A

i.m. Lorazepam, Haloperidol or Olanzapine

may be offered treatment with an antipsychotic

Antidepressants

  • People with dementia who also have major depressive disorder should be offered antidepressant medication
  • Avoid certain TCA and MAOI as they have anticholinergic properties